Mervic D. Kagho

Mervic D. Kagho

Auto-generated profile, based on publicly available information

Mervic D. Kagho

University of Gothenburg

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2025 in Small
Verified
Journal Article
Open access
MKMervic D. Kagho
Mervic D. Kagho
KSKatharina Schmidt
Katharina Schmidt
CLChristopher Lambert
Christopher Lambert
LJLili Jia
Lili Jia
VVVignesh Venkatakrishnan
Vignesh Venkatakrishnan
PKPhillip Klahn
Phillip Klahn
Migrastatic drugs targeting cell motility and suppressing invasiveness of solid tumors, have the potential to bring about a paradigm shift in the treatment of solid cancer. Cytochalasin B ( CB ) is a potent migrastatic compound, but its clinical use is limited by poor selectivity. Here, a NQO1‐responsive prodrug, BQTML‐CB is developed, synthesized in three steps from cytochalasin B derived from Preussia similis G22. BQTML‐CB is selectively activated in NQO1‐positive cancer cells, releasing active CB . In vitro , BQTML‐CB significantly inhibits proliferation and migration in NQO1‐positive U‐2OS cells, causing actin disruption and cytokinesis abnormalities, while sparing NQO1‐negative B16‐F1 cells. The prodrug shows reduced effects on human neutrophils, indicating reduced immunosuppressive activity of BQTML‐CB compared to CB . Co‐culture studies reveal a beneficial bystander effect, as cleaved CB diffused into adjacent NQO1‐deficient cells. These findings support BQTML‐CB as a cancer‐targeted prodrug with selective antiproliferative and migrastatic properties, highlighting the potential of C7‐OH‐modified cytochalasans in cancer therapy.

13 November 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LPLisa Pormetter
Lisa Pormetter
MPMarina Pfalz
Marina Pfalz
MKMervic D. Kagho
Mervic D. Kagho
PKPhillip Klahn
Phillip Klahn
HVHeiko Vogel
Heiko Vogel
UWUte Wittstock
Ute Wittstock
The glucosinolate-myrosinase system is a well-known chemical defense in the Brassicales order, which has been extensively studied in Arabidopsis thaliana . Here, we assessed natural variation of leaf glucosinolate content and profiles in seven species of the Brassicaceae family, using over 300 cauline leaf samples collected from wild populations in Germany and France. Total glucosinolate content varied substantially among individuals, populations and species. Analysis of glucosinolate profiles identified two types of profiles each for Cardamine amara and C. pratensis , and three profile types for C. impatiens . One profile type for each Cardamine species showed glucosinolate compositions distinct from previously described profile types. In contrast, the glucosinolate profiles of the other four species – Lepidium draba , Lunaria rediviva , Hesperis matronalis , and Descurainia sophia – were less variable. The obtained dataset paves the way for more detailed analyses of the genetic basis of glucosinolate biosynthesis in these species. Our data indicate that, among plutellid species whose larvae feed exclusively on cruciferous host plants, the oligophagous Eidophasia messingiella and Rhigognostis senilella are exposed to a diverse array of glucosinolate structures. In contrast, Plutella porrectella primarily encounters only a limited set of unusual glucosinolates when feeding on its preferred host plant, H. matronalis . Future research is required to evaluate whether this has led to specialized adaptations in this Lepidopteran herbivore. Furthermore, our study indicates that the unpredictable variation in total glucosinolate content as detected in our field-collected samples might pose a substantial challenge even to adapted herbivores.

27 September 2021 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
MKMervic D. Kagho
Mervic D. Kagho
HHHelen Hintersatz
Helen Hintersatz
AIAndreas Ihle
Andreas Ihle
HZHaoxuan Zeng
Haoxuan Zeng
HSHedda Schrey
Hedda Schrey
KBKlaus Banert
Klaus Banert

11 October 2024 in Journal of Natural Products
Verified
Journal Article
Open access
MKMervic D. Kagho
Mervic D. Kagho
KSKatharina Schmidt
Katharina Schmidt
CLChristopher Lambert
Christopher Lambert
TKThomas Kaufmann
Thomas Kaufmann
LJLili Jia
Lili Jia
PKPhillip Klahn
Phillip Klahn
In search of a more comprehensive structure-activity relationship (SAR) regarding the inhibitory effect of cytochalasin B (2) on actin polymerization, a virtual docking of 2 onto monomeric actin was conducted. This led to the identification of potentially important functional groups of 2 (i.e., the NH group of the isoindolone core (N-2) and the hydroxy groups at C-7 and C-20) involved in interactions with the residual amino acids of the binding pocket of actin. Chemical modifications of 2 at positions C-7, N-2, and C-20 led to derivatives 3-6, which were analyzed for their bioactivities. Compounds 3-5 exhibited reduced or no cytotoxicity in murine L929 fibroblasts compared to that of 2. Moreover, short- and long-term treatments of human osteosarcoma cells (U-2OS) with 3-6 affected the actin network to a variable extent, partially accompanied by the induction of multinucleation. Derivatives displaying acetylation at C-20 and N-2 were subjected to slow intracellular conversion to highly cytotoxic 2. Together, this study highlights the importance of the hydroxy group at C-7 and the NH function at N-2 for the potency of 2 on the inhibition of actin polymerization.

29 May 2025 in ChemBioChem
Verified
Journal Article
Open access
ACAishi Chakrabarti
Aishi Chakrabarti
CGCharity S. G. Ganskow
Charity S. G. Ganskow
MKMervic D. Kagho
Mervic D. Kagho
CJClaire. C. Jimidar
Claire. C. Jimidar
LWLorenz Wiese
Lorenz Wiese
PKPhillip Klahn
Phillip Klahn
Naturally occurring isothiocyanates (ITCs) display multiple interesting bioactivities, but their medicinal exploitation is very limited as ITCs are non‐druglike compounds with problematic pharmacokinetic properties. The concept of pseudoglucosinolates provides a novel prodrug approach for the release of ITCs which can be adjusted to different triggers such as enzymatic and chemical microenvironments. Herein, the first adaptation of this concept toward the release of ITCs in the presence of azoreductases within a turn‐on fluorescence probe is reported and its applicability in covalent protein labeling is underlined.

8 July 2024 in ChemRxiv
Verified
Preprint
Open access
PDF file
CJClaire C. Jimidar
Claire C. Jimidar
CGCharity S. G. Ganskow
Charity S. G. Ganskow
MKMervic D. Kagho
Mervic D. Kagho
ACAishi Chakrabarti
Aishi Chakrabarti
LWLorenz Wiese
Lorenz Wiese
PKPhillip Klahn
Phillip Klahn
Glucosinolates (GSLs) are secondary metabolites produced as part of an herbivore defence system in plants of the order Brassicales. GSLs release isothiocyanates (ITCs) upon activation by the myrosinase. Beyond their herbivore feeding deterrent properties, these ITCs have multiple interesting bioactivities. However, their release is limited by the presence of myrosinase. Here, we report the concept of pseudoglucosinolates (psGSLs) hijacking the natural release mechanism of GSLs for the release of ITCs and adapting it to nitroreductase as the triggering enzymes. We provide proof-of-concept for nitroreductase-responsive psGSLs and demonstrate their potential for peptide labelling, ITC-prodrug approaches and for in vivo applications using the nematode of C. elegans.